FR2364456B1 - - Google Patents

Info

Publication number
FR2364456B1
FR2364456B1 FR7722925A FR7722925A FR2364456B1 FR 2364456 B1 FR2364456 B1 FR 2364456B1 FR 7722925 A FR7722925 A FR 7722925A FR 7722925 A FR7722925 A FR 7722925A FR 2364456 B1 FR2364456 B1 FR 2364456B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7722925A
Other languages
French (fr)
Other versions
FR2364456A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Phadia AB
Original Assignee
Pharmacia Diagnostics AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Diagnostics AB filed Critical Pharmacia Diagnostics AB
Publication of FR2364456A1 publication Critical patent/FR2364456A1/fr
Application granted granted Critical
Publication of FR2364456B1 publication Critical patent/FR2364456B1/fr
Granted legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/962—Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/80—Fluorescent dyes, e.g. rhodamine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/819—Multifunctional antigen or antibody
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/821—Chemistry: analytical and immunological testing involving complement factors or complement systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/826—Additives, e.g. buffers, diluents, preservatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Rehabilitation Therapy (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
FR7722925A 1976-09-08 1977-07-26 Procede pour deceler et identifier des facteurs de rhumatismes Granted FR2364456A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7609906A SE441042B (sv) 1976-09-08 1976-09-08 Sett att pavisa rheumatoida faktorer

Publications (2)

Publication Number Publication Date
FR2364456A1 FR2364456A1 (fr) 1978-04-07
FR2364456B1 true FR2364456B1 (enExample) 1981-08-28

Family

ID=20328828

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7722925A Granted FR2364456A1 (fr) 1976-09-08 1977-07-26 Procede pour deceler et identifier des facteurs de rhumatismes

Country Status (8)

Country Link
US (1) US4153417A (enExample)
JP (1) JPS6057544B2 (enExample)
CA (1) CA1076937A (enExample)
DE (1) DE2707881C2 (enExample)
FR (1) FR2364456A1 (enExample)
GB (1) GB1576400A (enExample)
NL (1) NL7708078A (enExample)
SE (1) SE441042B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4302536A (en) * 1978-08-15 1981-11-24 Longenecker Robert W Colorimetric immunoassay process
US4342566A (en) * 1980-02-22 1982-08-03 Scripps Clinic & Research Foundation Solid phase anti-C3 assay for detection of immune complexes
US4434227A (en) * 1982-02-08 1984-02-28 Abbott Laboratories Immunoassay for class specific immunoglobulin antibodies
US4450231A (en) * 1982-03-31 1984-05-22 Biostar Medical Products, Inc. Immunoassay for determination of immune complexes with polymer-coated plastic base
US4582793A (en) * 1982-10-29 1986-04-15 Research Corporation Anti-RNA polymerase I antibody test for the diagnosis of rheumatological diseases
SE8304836D0 (sv) * 1983-09-09 1983-09-09 Pharmacia Ab Sett att bestemma forendringar i ledbrosk
CA1261257A (en) * 1984-09-19 1989-09-26 Helgi Valdimarsson Prognostic value of rheumatoid factor isotypes and their association with disease activity
US4914041A (en) * 1988-02-12 1990-04-03 Beckman Instruments, Inc. Reagent and method for detecting rheumatoid factor
DE68924783T2 (de) * 1988-09-30 1996-03-28 Neorx Corp Wässrige additivsysteme, verfahren und polymerteilchen.
US5066789A (en) * 1988-09-30 1991-11-19 Neorx Corporation Targeting substance-diagnostic/therapeutic agent conjugates having Schiff base linkages
US4986979A (en) * 1989-03-14 1991-01-22 Neorx Corporation Imaging tissue sites of inflammation
JPH02144560U (enExample) * 1989-05-12 1990-12-07
US6300480B1 (en) 1996-11-08 2001-10-09 Matsushita Electric Industrial Co., Ltd. Dye-labeled protein conjugate and method for preparing the same
JPH11322798A (ja) * 1998-05-14 1999-11-24 Matsushita Electric Ind Co Ltd 色素標識重合抗体およびその製造方法
US6303758B1 (en) 1996-11-08 2001-10-16 Matsushita Electric Industrial Co., Ltd. Dye-labeled and polymerized antibody and method for preparing the same
JP3601972B2 (ja) * 1998-05-14 2004-12-15 松下電器産業株式会社 色素標識タンパク質複合体およびその製造方法
JP3625250B2 (ja) * 1998-05-14 2005-03-02 松下電器産業株式会社 色素標識重合抗体およびその製造方法
US6303759B1 (en) 1996-11-08 2001-10-16 Matsushita Electric Industrial Co., Ltd. Dye-labeled and polymerized antibody and method for preparing the same
BR0017261A (pt) 2000-07-14 2003-07-29 Immunivest Corp Métodos para isolamento de uma bioentidade alvo de uma amostra biológica e de células de tumor com densidade de antìgeno baixa e, kits para inibir a agregação endógena de partìculas magnéticas coloidais no processamento de material biológico e, para isolamento de células de tumor de densidade de antìgeno baixa de uma amostra biológica com agregação ontrolada de partìculas magnéticas coloidais
US20060159680A1 (en) * 2005-01-14 2006-07-20 Smith Henry J Targeted apherisis for the treatment of rheumatoid arthritis
US20130068691A1 (en) * 2011-08-05 2013-03-21 Henry John Smith Targeted apheresis for the treatment of rheumatoid arthritis and immune disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1484727A (fr) * 1966-04-19 1967-06-16 Réactif immunologique et son procédé d'obtention
GB1179435A (en) * 1966-06-17 1970-01-28 Ortho Pharma Corp Stable Reagent for the Detection of Rheumatoid Arthritis
US3689632A (en) * 1969-01-06 1972-09-05 Kowa Co Rheumatoid agglutination test and reagent
GB1508132A (en) * 1974-05-20 1978-04-19 Technicon Instr Analysis of biological fluids

Also Published As

Publication number Publication date
SE441042B (sv) 1985-09-02
JPS6057544B2 (ja) 1985-12-16
DE2707881A1 (de) 1978-03-09
JPS5334918A (en) 1978-03-31
SE7609906L (sv) 1978-03-09
DE2707881C2 (de) 1985-05-30
US4153417A (en) 1979-05-08
CA1076937A (en) 1980-05-06
NL7708078A (nl) 1978-03-10
FR2364456A1 (fr) 1978-04-07
GB1576400A (en) 1980-10-08

Similar Documents

Publication Publication Date Title
FR2364456B1 (enExample)
FR2356167B1 (enExample)
FR2361575B1 (enExample)
FR2363824B1 (enExample)
JPS5538722Y2 (enExample)
JPS5519529B2 (enExample)
JPS5739351B2 (enExample)
JPS5627481B2 (enExample)
JPS5340459U (enExample)
JPS5349857U (enExample)
JPS5732668Y2 (enExample)
JPS545909Y2 (enExample)
JPS562192Y2 (enExample)
JPS5348809Y2 (enExample)
JPS5651409Y2 (enExample)
JPS572262Y2 (enExample)
JPS5381603U (enExample)
JPS52131599U (enExample)
JPS52105434U (enExample)
JPS52158090U (enExample)
JPS5318825U (enExample)
JPS5380383U (enExample)
CU34413A (enExample)
DD126834A1 (enExample)
DD125978A1 (enExample)

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse